Recordati: CVC explores sale of drug maker Recordati, says rival CEO
TOP STORY: CVC Capital Partners, the majority shareholder of Italy's pharmaceutical group Recordati, has reportedly initiated discussions with other Italian drugmakers regarding a potential sale, according to a report by Reuters citing Sergio Dompe, CEO of rival firm Dompé Farmaceutica.
Read full article »
Recordati engages in the research, development, manufacture, marketing and sale of pharmaceutical drugs for the treatment of rare diseases.
Read more